-
Cover image
-
Title page
-
Table of Contents
-
Copyright
-
Contributors
-
Forthcoming Issues
-
Preface
-
The Role of Personalized Medicine in Companion Animal Cardiology
-
Key points
-
Introduction
-
Inherited cardiomyopathies
-
Pharmacogenetics in cardiology and cardiovascular therapy
-
Clinical Application of Pharmacogenetic-Guided Pharmacotherapy
-
Future directions
-
Summary
-
Clinics care points
-
Funding support
-
Disclosure
-
Predicting Development of Hypertrophic Cardiomyopathy and Disease Outcomes in Cats
-
Key points
-
Introduction
-
Predicting development of hypertrophic cardiomyopathy
-
Predicting cardiovascular events and mortality in cats with hypertrophic cardiomyopathy
-
Conclusion
-
Summary
-
Clinics care points
-
Conflict of interest declaration
-
Funding
-
Advancing Treatments for Feline Hypertrophic Cardiomyopathy: The Role of Animal Models and Targeted Therapeutics
-
Key points
-
Introduction
-
Animal models of hypertrophic cardiomyopathy
-
Future directions – focus on fibrosis
-
Novel drug therapies for treatment of hypertrophic cardiomyopathy
-
Summary
-
Clinics care points
-
Disclosures
-
Preventing Cardiogenic Thromboembolism in Cats: Literature Gaps, Rational Recommendations, and Future Therapies
-
Key points
-
Introduction
-
Current understanding of cardiogenic arterial thromboembolism pathophysiology
-
Knowledge gap
-
Risk assessment for cats with cardiomyopathies and diagnosis of cardiogenic arterial thromboembolism
-
Recommendations for preventing cardiogenic arterial thromboembolism
-
Thrombolytic therapy
-
Future therapies
-
Summary
-
Clinics care points
-
Disclosure
-
Hypertrophic Cardiomyopathy–Advances in Imaging and Diagnostic Strategies
-
Key points
-
Introduction
-
Discussion
-
Future directions
-
Summary
-
Clinics care points
-
Disclosure
-
Funding
-
Supplementary data
-
Mitral Valve Repair–The Development and Rise of Options in the Veterinary World
-
Key points
-
Introduction
-
Summary
-
Clinics care points
-
Disclosure
-
Supplementary data
-
Beyond Angiotensin-Converting Enzyme Inhibitors: Modulation of the Renin–Angiotensin–Aldosterone System to Delay or Manage Congestive Heart Failure
-
Key points
-
Introduction
-
Discussion
-
Future approaches to renin–angiotensin–aldosterone system modulation
-
Summary
-
Clinics care points
-
Disclosure
-
The Role of Autoantibodies in Companion Animal Cardiac Disease
-
Key points
-
Introduction/Background
-
Current evidence in veterinary cardiology
-
Discussion
-
Clinics care points
-
Disclosure
-
The Genetics of Canine Pulmonary Valve Stenosis
-
Key points
-
Introduction
-
Canine breed predispositions
-
Mode of inheritance
-
Human genetics
-
RASopathies
-
Additional syndromes associated with pulmonary valve stenosis
-
Transcription factors
-
Microdeletions and microduplications
-
Future genetic work
-
Summary
-
Clinics care points
-
Disclosure
-
Advances in the Treatment of Pulmonary Valve Stenosis
-
Key points
-
Background
-
Anatomy of pulmonary valve stenosis in dogs
-
Indications for pulmonary valve stenosis therapy
-
Therapeutic options for pulmonary valve stenosis
-
Balloon pulmonary valvuloplasty
-
High-pressure balloon pulmonary valvuloplasty
-
Cutting-balloon dilation for pulmonary valve dysplasia
-
Transpulmonary stent implantation
-
Summary
-
Clinics care points
-
Disclosure
-
Supplementary data
-
Treating Stubborn Cardiac Arrhythmias—Looking Toward the Future
-
Key points
-
Implantable cardioverter-defibrillator
-
Electrophysiological studies and catheter ablation
-
Three-dimensional electroanatomical mapping
-
Stereotactic arrhythmia radiotherapy
-
Summary
-
Disclosure
-
Supplementary data
-
The Role of Point-of-Care Ultrasound in Managing Cardiac Emergencies
-
Key points
-
Introduction
-
Image acquisition and recognizing normal anatomy
-
Severe left heart disease and left-sided congestive heart failure in dogs
-
Severe heart disease and congestive heart failure in cats
-
Severe right heart disease and right-sided congestive heart failure
-
Pericardial effusion and cardiac tamponade
-
Using point-of-care ultrasound to monitor cardiac emergencies
-
Summary
-
Clinics care points
-
Disclosure